Light Mode
$185.76 ↓ -0.89 (-0.48%) Trading Down from the previous close of $186.65
+3.19 (+1.74%) / 6M
Momentum, market sentiment, and recent alerts
AZN reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +128.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.